| MSD Merck Sharp & Dohme AG - Winrevair 45 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| 69787 | | 01 | | Winrevair 45 mg | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | C02KX | | Antihypertensives for Pulmonary Arterial Hypertension | | 16.10.2024 | | |
|
| Composition |
| Praeparatio cryodesiccata: sotaterceptum 45 mg, acidum citricum, trinatrii citras dihydricus corresp. natrium 0.49 mg, polysorbatum 80, saccharum, pro vitro.
Solvens: aqua ad iniectabile q.s. ad solutionem pro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose |
|---|
| Sotaterceptum | 45 mg |
| | BAG: Active Agent | Dose |
|---|
| Sotaterceptum | 45 mg |
| | | | Inactive agents |
|---|
| Citric Acid | | Polysorbatum 80 | | Saccharum | | Trinatrii Citras Dihydricus |
| |
| Solvens | | | aqua ad iniectabile q.s. ad solutionem pro | | | | | | BAG: Active Agent | Dose |
|---|
| Sotaterceptum | 45 mg |
|
| Solvens | | | aqua ad iniectabile q.s. ad solutionem pro | | | | | | BAG: Active Agent | Dose |
|---|
| Sotaterceptum | 45 mg |
|
| Solvens | | | aqua ad iniectabile q.s. ad solutionem pro | | | | | | BAG: Active Agent | Dose |
|---|
| Sotaterceptum | 45 mg |
|
| Solvens | | | aqua ad iniectabile q.s. ad solutionem pro | | | | | | BAG: Active Agent | Dose |
|---|
| Sotaterceptum | 45 mg |
|
| Solvens | | | aqua ad iniectabile q.s. ad solutionem pro | | | | | | BAG: Active Agent | Dose |
|---|
| Sotaterceptum | 45 mg |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 5956.94 | 6419.60 | B | SL | No | | 002 | 2 | 11913.87 | 12531.45 | B | SL | No |
|
